We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Joint Advisory Committee Endorses Takeda’s Gout Drug
Joint Advisory Committee Endorses Takeda’s Gout Drug
A joint FDA advisory committee voted 19 to two on Friday in favor of the benefit-risk profile of Takeda’s Uloric (febuxostat) for treatment of excessive uric acid in the blood of gout patients.